Biotechnology and the LawAmerican Bar Association, 2007 - 957 lappuses The book is written to help lawyers faced with the challenge of identifying the legal issues and processes that must be faced by their clients in building, marketing, and protecting a biotech business. The contributors are experts in this specialized area and provide thorough, yet accessible, overviews of biotech subspecialties with an eye to practical application. A biotech legal practice involves specialized subject matter and regulatory schemes that, generally, are not part of the business lawyer's repertoire and which can present many hazards for the uninitiated. Because of the expansion in biotech practice beyond the traditional organizations and their representatives, this guide was written to help lawyers find their way through the biotech maze. |
No grāmatas satura
1.–5. rezultāts no 84.
xiv. lappuse
... Institutional Animal Care and Use Committee Guidebook .... 422 5. FDA Considerations ....... ...... 423 6 . CDC Considerations .......... 424 7 . State Law ..... 424 8 . Conclusion ................. 424 B. Other Regulatory Schemes ...
... Institutional Animal Care and Use Committee Guidebook .... 422 5. FDA Considerations ....... ...... 423 6 . CDC Considerations .......... 424 7 . State Law ..... 424 8 . Conclusion ................. 424 B. Other Regulatory Schemes ...
xvii. lappuse
... Institutional Review Board ( IRB ) d . Principal Investigator ( PI ) .......... 479 479 480 .... 481 ...... 481 ...... 481 ..... 483 .... 484 .... 484 485 ..... 486 .... 487 487 .... 488 490 490 ............... 490 The Legal Relationships ...
... Institutional Review Board ( IRB ) d . Principal Investigator ( PI ) .......... 479 479 480 .... 481 ...... 481 ...... 481 ..... 483 .... 484 .... 484 485 ..... 486 .... 487 487 .... 488 490 490 ............... 490 The Legal Relationships ...
xx. lappuse
... i . Exemption from Law ........ ii . Institutional Review Boards iii . Clinical Hold ............... 591 .... 592 592 ..... 593 593 591 .... 591 ..... 591 iv . Types of INDs ..... .... 595 v . XX Biotechnology and the Law.
... i . Exemption from Law ........ ii . Institutional Review Boards iii . Clinical Hold ............... 591 .... 592 592 ..... 593 593 591 .... 591 ..... 591 iv . Types of INDs ..... .... 595 v . XX Biotechnology and the Law.
xxv. lappuse
... Institutions , Regulatory Bodies , and Legislative Framework ... 1. The European Commission ...... 2. The European Medicines Agency 3. National Regulatory Bodies ( Competent Authorities ) 4. European Legislation and Other Instruments ...
... Institutions , Regulatory Bodies , and Legislative Framework ... 1. The European Commission ...... 2. The European Medicines Agency 3. National Regulatory Bodies ( Competent Authorities ) 4. European Legislation and Other Instruments ...
xliv. lappuse
... institutions with risk management , regulatory , licensure and medi- cal staff issues , preparation and review of health - care - related contracts , HIPAA compliance and violations and clinical research trials . Ms. O'Brien received ...
... institutions with risk management , regulatory , licensure and medi- cal staff issues , preparation and review of health - care - related contracts , HIPAA compliance and violations and clinical research trials . Ms. O'Brien received ...
Saturs
IV | 1 |
VI | 4 |
VIII | 5 |
X | 6 |
XII | 7 |
XIV | 8 |
XVI | 9 |
XVIII | 10 |
CDLXXIV | 484 |
CDLXXVI | 485 |
CDLXXVII | 486 |
CDLXXVIII | 487 |
CDLXXIX | 488 |
CDLXXX | 489 |
CDLXXXI | 490 |
CDLXXXIV | 491 |
XX | 11 |
XXIII | 12 |
XXIV | 13 |
XXV | 25 |
XXIX | 26 |
XXXI | 28 |
XXXII | 29 |
XXXIII | 30 |
XXXIV | 31 |
XXXV | 34 |
XXXVI | 35 |
XXXVII | 38 |
XXXVIII | 39 |
XXXIX | 41 |
XL | 42 |
XLI | 43 |
XLII | 45 |
XLIII | 46 |
XLIV | 49 |
XLV | 51 |
XLVI | 52 |
XLVII | 53 |
XLVIII | 57 |
XLIX | 58 |
LI | 60 |
LII | 62 |
LIII | 63 |
LIV | 64 |
LV | 66 |
LVI | 69 |
LVII | 70 |
LVIII | 72 |
LIX | 73 |
LXII | 74 |
LXIII | 75 |
LXVI | 76 |
LXVIII | 77 |
LXX | 78 |
LXXI | 79 |
LXXIII | 80 |
LXXIV | 81 |
LXXV | 82 |
LXXIX | 83 |
LXXXII | 84 |
LXXXIII | 88 |
LXXXV | 91 |
LXXXVI | 95 |
LXXXVIII | 97 |
LXXXIX | 99 |
XCI | 100 |
XCII | 105 |
XCIII | 107 |
XCIV | 108 |
XCV | 109 |
XCVI | 110 |
XCVII | 111 |
XCIX | 112 |
CI | 113 |
CIII | 114 |
CIV | 115 |
CV | 117 |
CVI | 118 |
CVIII | 119 |
CIX | 121 |
CX | 122 |
CXI | 124 |
CXII | 126 |
CXIII | 127 |
CXIV | 132 |
CXV | 139 |
CXVIII | 140 |
CXX | 141 |
CXXI | 142 |
CXXII | 143 |
CXXIV | 145 |
CXXVI | 146 |
CXXVII | 147 |
CXXVIII | 148 |
CXXIX | 149 |
CXXX | 150 |
CXXXII | 151 |
CXXXIV | 152 |
CXXXVI | 154 |
CXXXVIII | 155 |
CXLI | 156 |
CXLIII | 158 |
CXLV | 160 |
CXLVII | 161 |
CXLVIII | 162 |
CXLIX | 168 |
CL | 169 |
CLI | 170 |
CLII | 171 |
CLIV | 172 |
CLVI | 173 |
CLVII | 174 |
CLVIII | 175 |
CLXI | 176 |
CLXVIII | 177 |
CLXXII | 178 |
CLXXVIII | 179 |
CLXXXIII | 180 |
CLXXXIV | 183 |
CLXXXVI | 184 |
CLXXXVIII | 185 |
CXC | 186 |
CXCII | 187 |
CXCV | 188 |
CXCVII | 189 |
CCII | 190 |
CCIV | 191 |
CCVI | 192 |
CCIX | 193 |
CCXIII | 194 |
CCXVIII | 195 |
CCXXII | 196 |
CCXXIII | 197 |
CCXXVII | 198 |
CCXXVIII | 199 |
CCXXX | 203 |
CCXXXI | 204 |
CCXXXIII | 206 |
CCXXXIV | 209 |
CCXXXV | 210 |
CCXXXVII | 212 |
CCXXXVIII | 213 |
CCXXXIX | 214 |
CCXLI | 215 |
CCXLIII | 216 |
CCXLIV | 217 |
CCXLV | 218 |
CCXLVII | 219 |
CCXLIX | 220 |
CCL | 221 |
CCLII | 222 |
CCLIV | 223 |
CCLVII | 224 |
CCLIX | 225 |
CCLXI | 226 |
CCLXIII | 227 |
CCLXIV | 228 |
CCLXVII | 230 |
CCLXIX | 231 |
CCLXX | 232 |
CCLXXII | 233 |
CCLXXIII | 234 |
CCLXXV | 235 |
CCLXXVII | 236 |
CCLXXVIII | 237 |
CCLXXIX | 239 |
CCLXXXI | 240 |
CCLXXXII | 241 |
CCLXXXIV | 253 |
CCLXXXV | 265 |
CCLXXXVI | 266 |
CCLXXXVII | 267 |
CCLXXXVIII | 268 |
CCLXXXIX | 270 |
CCXC | 271 |
CCXCI | 272 |
CCXCIII | 273 |
CCXCV | 274 |
CCXCVIII | 275 |
CCCII | 276 |
CCCIV | 277 |
CCCVII | 281 |
CCCX | 282 |
CCCXIII | 283 |
CCCXIV | 285 |
CCCXVI | 286 |
CCCXVII | 287 |
CCCXX | 288 |
CCCXXIII | 289 |
CCCXXVII | 290 |
CCCXXIX | 291 |
CCCXXXI | 299 |
CCCXXXIII | 300 |
CCCXXXIV | 301 |
CCCXXXVII | 302 |
CCCXXXIX | 303 |
CCCXLII | 304 |
CCCXLIV | 305 |
CCCXLVI | 307 |
CCCXLVII | 308 |
CCCXLVIII | 309 |
CCCXLIX | 310 |
CCCL | 312 |
CCCLII | 314 |
CCCLIV | 315 |
CCCLV | 318 |
CCCLVI | 325 |
CCCLVII | 326 |
CCCLVIII | 327 |
CCCLIX | 328 |
CCCLX | 330 |
CCCLXII | 331 |
CCCLXIV | 332 |
CCCLXVI | 337 |
CCCLXVII | 340 |
CCCLXVIII | 342 |
CCCLXIX | 344 |
CCCLXXI | 345 |
CCCLXXII | 346 |
CCCLXXIII | 347 |
CCCLXXIV | 348 |
CCCLXXVI | 349 |
CCCLXXVIII | 350 |
CCCLXXIX | 351 |
CCCLXXXI | 352 |
CCCLXXXIV | 353 |
CCCLXXXVII | 354 |
CCCLXXXIX | 356 |
CCCXC | 358 |
CCCXCI | 407 |
CCCXCII | 408 |
CCCXCV | 411 |
CCCXCVI | 412 |
CCCXCVII | 415 |
CCCXCVIII | 417 |
CCCXCIX | 418 |
CD | 419 |
CDI | 420 |
CDII | 421 |
CDIII | 422 |
CDIV | 423 |
CDV | 424 |
CDVIII | 425 |
CDIX | 433 |
CDX | 434 |
CDXII | 438 |
CDXIII | 439 |
CDXIV | 441 |
CDXV | 442 |
CDXVII | 445 |
CDXVIII | 446 |
CDXIX | 449 |
CDXX | 450 |
CDXXI | 451 |
CDXXII | 452 |
CDXXIII | 453 |
CDXXV | 454 |
CDXXVI | 455 |
CDXXVII | 456 |
CDXXXI | 457 |
CDXXXIV | 458 |
CDXXXVII | 459 |
CDXXXIX | 460 |
CDXLII | 461 |
CDXLIV | 462 |
CDXLVI | 463 |
CDXLIX | 464 |
CDLI | 465 |
CDLIII | 469 |
CDLVI | 470 |
CDLVIII | 471 |
CDLIX | 472 |
CDLXI | 475 |
CDLXIV | 476 |
CDLXVII | 477 |
CDLXVIII | 479 |
CDLXIX | 480 |
CDLXX | 481 |
CDLXXIII | 483 |
CDLXXXVI | 493 |
CDLXXXVII | 494 |
CDLXXXVIII | 495 |
CDLXXXIX | 497 |
CDXCI | 498 |
CDXCII | 499 |
CDXCIV | 500 |
CDXCVII | 501 |
CDXCVIII | 509 |
CDXCIX | 512 |
DI | 518 |
DII | 519 |
DIII | 521 |
DV | 523 |
DVI | 524 |
DVII | 525 |
DVIII | 526 |
DIX | 528 |
DXII | 529 |
DXV | 530 |
DXVII | 531 |
DXVIII | 532 |
DXIX | 534 |
DXXI | 536 |
DXXIII | 537 |
DXXIV | 539 |
DXXVIII | 542 |
DXXIX | 543 |
DXXX | 544 |
DXXXI | 545 |
DXXXII | 546 |
DXXXIII | 547 |
DXXXV | 549 |
DXXXVII | 550 |
DXXXVIII | 551 |
DXL | 552 |
DXLI | 553 |
DXLIII | 554 |
DXLVIII | 555 |
DL | 563 |
DLI | 564 |
DLIII | 565 |
DLV | 566 |
DLVI | 567 |
DLVIII | 568 |
DLIX | 569 |
DLX | 571 |
DLXI | 574 |
DLXIII | 576 |
DLXIV | 578 |
DLXV | 579 |
DLXVII | 580 |
DLXIX | 581 |
DLXXI | 582 |
DLXXII | 583 |
DLXXIII | 586 |
DLXXV | 587 |
DLXXVI | 588 |
DLXXVII | 591 |
DLXXVIII | 592 |
DLXXIX | 593 |
DLXXXI | 595 |
DLXXXIII | 596 |
DLXXXIV | 597 |
DLXXXV | 600 |
DLXXXVII | 602 |
DLXXXIX | 603 |
DXC | 605 |
DXCII | 607 |
DXCIII | 608 |
DXCIV | 609 |
DXCV | 610 |
DXCVIII | 612 |
DXCIX | 614 |
DC | 615 |
DCI | 623 |
DCII | 625 |
DCIII | 627 |
DCIV | 628 |
DCV | 629 |
DCVI | 630 |
DCVII | 631 |
DCVIII | 632 |
DCXI | 633 |
DCXIII | 635 |
DCXIV | 636 |
DCXV | 637 |
DCXVI | 639 |
DCXVII | 641 |
DCXVIII | 642 |
DCXX | 643 |
DCXXI | 644 |
DCXXIV | 645 |
DCXXVII | 646 |
DCXXIX | 647 |
DCXXX | 648 |
DCXXXI | 661 |
DCXXXII | 662 |
DCXXXIII | 664 |
DCXXXIV | 666 |
DCXXXV | 668 |
DCXXXVI | 670 |
DCXXXIX | 671 |
DCXLI | 672 |
DCXLIII | 673 |
DCXLIV | 674 |
DCXLV | 677 |
DCXLVI | 679 |
DCXLVIII | 680 |
DCXLIX | 682 |
DCL | 683 |
DCLII | 684 |
DCLIII | 686 |
DCLV | 687 |
DCLVI | 691 |
DCLX | 692 |
DCLXI | 693 |
DCLXII | 694 |
DCLXIV | 695 |
DCLXV | 696 |
DCLXVI | 699 |
DCLXVIII | 700 |
DCLXIX | 701 |
DCLXXI | 707 |
DCLXXII | 708 |
DCLXXIV | 709 |
DCLXXV | 710 |
DCLXXIX | 711 |
DCLXXXI | 712 |
DCLXXXIV | 713 |
DCLXXXV | 714 |
DCLXXXVI | 715 |
DCLXXXVII | 716 |
DCLXXXIX | 718 |
DCXC | 721 |
DCXCI | 722 |
DCXCII | 723 |
DCXCIV | 724 |
DCXCVII | 725 |
DCXCVIII | 726 |
DCXCIX | 728 |
DCCI | 729 |
DCCIII | 730 |
DCCV | 731 |
DCCVI | 732 |
DCCVII | 733 |
DCCVIII | 735 |
DCCXIII | 737 |
DCCXIV | 739 |
DCCXVI | 740 |
DCCXVII | 741 |
DCCXVIII | 742 |
DCCXXI | 743 |
DCCXXIII | 744 |
DCCXXIV | 745 |
DCCXXVI | 746 |
DCCXXVIII | 747 |
DCCXXIX | 748 |
DCCXXX | 749 |
DCCXXXI | 750 |
DCCXXXIII | 751 |
DCCXXXV | 753 |
DCCXXXVII | 755 |
DCCXXXVIII | 756 |
DCCXL | 757 |
DCCXLII | 758 |
DCCXLIII | 759 |
DCCXLIV | 761 |
DCCXLV | 762 |
DCCXLVI | 763 |
DCCXLVIII | 764 |
DCCLI | 765 |
DCCLII | 766 |
DCCLIII | 767 |
DCCLVI | 768 |
DCCLVII | 769 |
DCCLX | 771 |
DCCLXII | 772 |
DCCLXIII | 773 |
DCCLXV | 774 |
DCCLXVI | 775 |
DCCLXVII | 776 |
DCCLXIX | 777 |
DCCLXXI | 779 |
DCCLXXII | 780 |
DCCLXXIV | 781 |
DCCLXXVI | 782 |
DCCLXXIX | 783 |
DCCLXXXII | 784 |
DCCLXXXIII | 785 |
DCCLXXXIV | 786 |
DCCLXXXV | 787 |
DCCLXXXVI | 788 |
DCCLXXXIX | 789 |
DCCXC | 790 |
DCCXCI | 791 |
DCCXCIII | 792 |
DCCXCV | 793 |
DCCXCVIII | 794 |
DCCXCIX | 795 |
DCCCI | 796 |
DCCCV | 797 |
DCCCVI | 798 |
DCCCVIII | 813 |
DCCCIX | 815 |
DCCCX | 816 |
DCCCXII | 817 |
DCCCXIII | 818 |
DCCCXIV | 819 |
DCCCXVII | 821 |
DCCCXVIII | 822 |
DCCCXIX | 824 |
DCCCXX | 825 |
DCCCXXI | 826 |
DCCCXXII | 828 |
DCCCXXIII | 829 |
DCCCXXIV | 830 |
DCCCXXV | 831 |
DCCCXXVI | 833 |
DCCCXXVII | 834 |
DCCCXXVIII | 835 |
DCCCXXIX | 836 |
DCCCXXXI | 837 |
DCCCXXXII | 838 |
DCCCXXXIII | 840 |
DCCCXXXIV | 841 |
DCCCXXXV | 843 |
DCCCXXXVII | 857 |
DCCCXXXVIII | 858 |
DCCCXXXIX | 859 |
DCCCXLII | 863 |
DCCCXLIV | 864 |
DCCCXLV | 865 |
DCCCXLVI | 866 |
DCCCXLVII | 867 |
DCCCXLVIII | 868 |
DCCCL | 869 |
DCCCLI | 870 |
DCCCLIII | 871 |
DCCCLV | 872 |
DCCCLVI | 873 |
DCCCLVIII | 874 |
DCCCLX | 875 |
DCCCLXI | 880 |
DCCCLXIV | 881 |
DCCCLXVII | 882 |
DCCCLXX | 883 |
DCCCLXXI | 884 |
DCCCLXXIII | 885 |
DCCCLXXIV | 886 |
DCCCLXXVI | 887 |
DCCCLXXVII | 888 |
DCCCLXXVIII | 893 |
DCCCLXXIX | 894 |
DCCCLXXX | 896 |
DCCCLXXXI | 900 |
DCCCLXXXIII | 912 |
DCCCLXXXIV | 918 |
DCCCLXXXVI | 923 |
DCCCLXXXVII | 933 |
935 | |
Citi izdevumi - Skatīt visu
Biotechnology and the Law Hugh B. Wellons,Robert F. Copple,Bill Wofford Priekšskatījums nav pieejams - 2020 |
Bieži izmantoti vārdi un frāzes
addition agency agreement amended animal drugs approval authorization Bayh-Dole Act biological product biotech company biotechnology biotechnology company cell chapter claims clinical trials collaboration commercial company's compliance conduct confidentiality contract contractor Covered Entity disclose disclosure documents employee ensure European European Commission European Medicines Agency exemption FDA's federal filing founders funding genetic GMOs grant Guidance hazardous waste HIPAA human IACUC individual infringement Initial Public Offering intellectual property invention investigational investors issues license licensor limited litigation manufacturing medical devices Medicare medicinal products ment option organization parties partner patent application payment pharmaceutical pharmacovigilance potential Practice Points preclinical research prior art Privacy procedures protection registration regulations regulatory requirements risk royalty safety shares specific sponsor tion trade secret trademark VSTA